Skip to main content

Table 1 Descriptive characteristics of NHANES participants

From: Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism

Characteristics

General population

Population without CKD

Population with CKD

P-value

Sex

0.003

 Male

4543 (46.74)

3870 (46.35)

673 (39.91)

 

 Female

5176 (53.26)

4329 (53.65)

847 (60.09)

 

 Age in years

53.96 (0.16)

53.11 (0.17)

59.81 (0.33)

 < 0.001

Age

 < 0.001

 40–50

3445 (35.45)

3139 (41.58)

306 (22.25)

 

 50–60

2799 (28.8)

2453 (33.80)

346 (25.63)

 

 60–70

2341 (24.09)

1871 (18.02)

470 (29.14)

 

  >  = 70

1134 (11.67)

736 (6.60)

398 (22.97)

 

Race

 < 0.001

 Mexican American

1643 (16.91)

1380 (7.29)

263 (8.09)

 

 Non-Hispanic White

4002 (41.18)

3400 (71.88)

602 (67.58)

 

 Non-Hispanic Black

1925 (19.81)

1559 (9.01)

366 (12.62)

 

 Other Races

2149 (22.11)

1860 (11.83)

289 (11.71)

 

Educational attainment

 < 0.001

  < 11th grade

2683 (27.61)

2177 (15.44)

506 (21.18)

 

 High school graduate

2135 (21.97)

1785 (21.71)

350 (23.65)

 

 Some college or AA degree

2653 (27.3)

2253 (30.48)

400 (30.05)

 

 College graduate or above

2248 (23.13)

1984 (32.37)

264 (25.13)

 

BMI

 < 0.001

 Normal

2595 (26.7)

2258 (28.33)

337 (22.65)

 

 Overweight

3382 (34.8)

2913 (35.92)

469 (31.21)

 

 Obese

3742 (38.5)

3028 (35.75)

714 (46.13)

 

Smoking status

0.001

 Never

5182 (53.32)

4436 (54.41)

746 (48.26)

 

 Former

2485 (25.57)

2059 (26.21)

426 (31.13)

 

 Current

2052 (21.11)

1704 (19.38)

348 (20.60)

 

CVD

 < 0.001

 Yes

721 (7.42)

472 (4.44)

249 (12.87)

 

 No

8998 (92.58)

7727 (95.56)

1271 (87.13)

 

DM

 < 0.001

 Yes

1670 (17.18)

1131 (9.87)

539 (28.48)

 

 No

8049 (82.82)

7068 (90.13)

981 (71.52)

 

Hypertension

 < 0.001

 Yes

4386 (45.13)

3343 (36.94)

1043 (63.34)

 

 No

5333 (54.87)

4856 (63.06)

477 (36.66)

 

Klotho (pg/ml)

859.53 (5.97)

863.18 (6.36)

834.54 (9.88)

0.008

Biomarkers of lipid

 HDL (mg/dl)

55.33 (0.35)

55.42 (0.34)

54.70 (1.01)

0.464

 LDL (mg/dl)

126.38 (0.74)

126.77 (0.75)

123.52 (1.92)

0.094

 TC (mg/dl)

209.94 (0.75)

209.55 (0.75)

212.68 (1.63)

0.047

 TG (mg/dl)

162.13 (2.16)

159.07 (2.34)

183.05 (4.67)

 < 0.001

Biomarkers of inflammation

 WBC (1000 cells/ul)

6.57 (0.06)

6.51 (0.06)

7.01 (0.11)

 < 0.001

 Neu (1000 cell/ul)

3.87 (0.04)

3.82 (0.04)

4.27 (0.09)

 < 0.001

 Lym (1000 cell/ul)

1.92 (0.02)

1.92 (0.02)

1.92 (0.05)

0.966

 Mono (1000 cell/ul)

0.53 (0.01)

0.52 (0.01)

0.56 (0.01)

0.004

 SII

527.75 (8.13)

517.70 (8.20)

601.61 (19.63)

 < 0.001

 NLR

2.17 (0.03)

2.12 (0.03)

2.49 (0.07)

 < 0.001

 MLR

0.29 (0.00)

0.29 (0.00)

0.32 (0.01)

 < 0.001

 PLR

136.50 (1.39)

136.20 (1.45)

138.76 (2.28)

0.269

 SIRI

1.17 (0.02)

1.14 (0.02)

1.43 (0.05)

 < 0.001

 PIV

288.06 (5.47)

279.62 (5.64)

350.07 (15.86)

 < 0.001

Biomarkers of renal function

 eGFR (mL/min/1.73m2)

89.44 (0.35)

91.59 (0.31)

74.72 (0.90)

 < 0.001

 Serum creatinine (mg/dl)

0.87 (0.00)

0.84 (0.00)

1.08 (0.02)

 < 0.001

 UACR (mg/g)

16.09 (0.14)

16.09 (0.14)

16.10 (0.22)

0.937

 Uric acid (mg/dl)

5.40 (0.03)

5.33 (0.03)

5.94 (0.06)

 < 0.001

 Serum urea nitrogen (mg/dl)

13.58 (0.10)

13.19 (0.09)

16.25 (0.25)

 < 0.001

  1. CKD, chronic kidney disease; BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; HDL, high density lipoprotein; LDL, low density lipoprotein; TC, total cholesterol; TG, triglyceride; WBC, white blood cell; Neu, neutrophil; Lym, lymphocyte; Mono, monocyte; SII, systemic immune-inflammation index; NLR, neutrophil to lymphocyte ratio; MLR, monocyte to lymphocyte ratio; PLR, platelet to lymphocyte ratio; SIRI, systemic inflammatory response index; PIV, pan-immune-inflammation value; eGFR, estimated glomerular filtration rate; UACR, Urine Albumin-to-Creatinine Ratio. Continuous variables were presented as Mean ± SD, and categorical variables were presented as N (%)